Mark Kotter | |
|---|---|
 | |
| Born | Mark Reinhard Kotter February 14, 1971 Calgary, Canada |
| Nationality | Austrian, Canadian |
| Alma mater | University of Graz, University of Cambridge |
| Known for | cell programming, degenerative cervical myelopathy |
| Scientific career | |
| Fields | Biology, Neurosciences, Medicine |
| Institutions | University of Cambridge, bit.bio, clock.bio, Myelopathy.org, Meatable |
| Thesis | Macrophages and CNS Remyelination |
| Doctoral advisor | Robin Franklin |
| Website | https://www.linkedin.com/in/mark-kotter/ https://x.com/markkotter |
Mark Kotter (born 1971) is a renowned neurosurgeon, biologist, and entrepreneur. He is the founder and CEO of the cell coding company bit.bio, and a pioneer in the development of opti-ox technology, which revolutionises the production of human cells for therapeutic purposes. Kotter is also known for his significant contributions to brain regeneration research and his involvement in the field of cultured meat as the co-founder of Meatable.